特刊“儿童血液病中的个性化医疗”。
Special Issue "Personalized Medicine in Blood Disease of Children".
作者信息
Ceci Adriana, Kountouris Petros, Didio Antonella, Bonifazi Fedele
机构信息
Fondazione per la Ricerca Farmacologica Gianni Benzi Onlus, 70010 Valenzano, Italy.
Molecular Genetics Thalassaemia Department, The Cyprus Institute of Neurology & Genetics, Nicosia 2371, Cyprus.
出版信息
J Pers Med. 2024 Mar 5;14(3):285. doi: 10.3390/jpm14030285.
Abstract
Personalized medicine is defined as a medical model using the characterization of individuals' phenotypes and genotypes (e [...].
摘要
个性化医疗被定义为一种利用个体表型和基因型特征的医学模式（e [...].）
相似文献
1
Special Issue "Personalized Medicine in Blood Disease of Children".
J Pers Med. 2024 Mar 5;14(3):285. doi: 10.3390/jpm14030285.
2
Moving Toward a Precision-Based, Personalized Framework for Prevention Science: Introduction to the Special Issue.
Prev Sci. 2019 Jan;20(1):1-9. doi: 10.1007/s11121-018-0955-9.
3
Personalized medicine: from genotypes, molecular phenotypes and the quantified self, towards improved medicine.
Pac Symp Biocomput. 2015:342-6.
4
Personalized laboratory medicine in the digital health era: recent developments and future challenges.
Clin Chem Lab Med. 2023 Sep 28;62(3):402-409. doi: 10.1515/cclm-2023-0808. Print 2024 Feb 26.
5
Fundamentals of Pharmacogenetics in Personalized, Precision Medicine.
Clin Lab Med. 2016 Sep;36(3):447-59. doi: 10.1016/j.cll.2016.05.006. Epub 2016 Jul 2.
6
Prakriti and its associations with metabolism, chronic diseases, and genotypes: Possibilities of new born screening and a lifetime of personalized prevention.
J Ayurveda Integr Med. 2014 Jan;5(1):15-24. doi: 10.4103/0975-9476.128848.
7
Personalized medicine and the role of health economics and outcomes research: issues, applications, emerging trends, and future research.
Value Health. 2013 Sep-Oct;16(6 Suppl):S1-3. doi: 10.1016/j.jval.2013.06.004.
8
Milestones in Personalized Medicine: From the Ancient Time to Nowadays-the Provocation of COVID-19.
Front Genet. 2020 Nov 30;11:569175. doi: 10.3389/fgene.2020.569175. eCollection 2020.
9
Engineering hydrogels for personalized disease modeling and regenerative medicine.
Acta Biomater. 2021 Sep 15;132:4-22. doi: 10.1016/j.actbio.2021.04.020. Epub 2021 Apr 18.
10
Does personalized medicine exist and can you test it in a clinical trial?
Int J Stroke. 2015 Oct;10(7):994-9. doi: 10.1111/ijs.12597. Epub 2015 Aug 18.
本文引用的文献
1
Challenges and Opportunities of Precision Medicine in Sickle Cell Disease: Novel European Approach by GenoMed4All Consortium and ERN-EuroBloodNet.
Hemasphere. 2023 Feb 22;7(3):e844. doi: 10.1097/HS9.0000000000000844. eCollection 2023 Mar.
2
Transition in Sickle Cell Disease (SCD): A German Consensus Recommendation.
J Pers Med. 2022 Jul 17;12(7):1156. doi: 10.3390/jpm12071156.
3
Global Globin Network Consensus Paper: Classification and Stratified Roadmaps for Improved Thalassaemia Care and Prevention in 32 Countries.
J Pers Med. 2022 Mar 31;12(4):552. doi: 10.3390/jpm12040552.
4
Link between Genotype and Multi-Organ Iron and Complications in Children with Transfusion-Dependent Thalassemia.
J Pers Med. 2022 Mar 4;12(3):400. doi: 10.3390/jpm12030400.
5
The Prevalence of β-Thalassemia and Other Hemoglobinopathies in Kuwaiti Premarital Screening Program: An 11-Year Experience.
J Pers Med. 2021 Sep 29;11(10):980. doi: 10.3390/jpm11100980.
6
Pregnancies and Neonatal Outcomes in Patients with Sickle Cell Disease (SCD): Still a (High-)Risk Constellation?
J Pers Med. 2021 Aug 30;11(9):870. doi: 10.3390/jpm11090870.
7
The International Hemoglobinopathy Research Network (INHERENT): An international initiative to study the role of genetic modifiers in hemoglobinopathies.
Am J Hematol. 2021 Nov 1;96(11):E416-E420. doi: 10.1002/ajh.26323. Epub 2021 Aug 30.
8
Unique Polymorphisms at , and Loci Associated with HbF in Kuwaiti Patients with Sickle Cell Disease.
J Pers Med. 2021 Jun 17;11(6):567. doi: 10.3390/jpm11060567.
9
Innovative Treatments for Rare Anemias.
Hemasphere. 2021 Jun 1;5(6):e576. doi: 10.1097/HS9.0000000000000576. eCollection 2021 Jun.
10
Diagnosis of Sickle Cell Disease and HBB Haplotyping in the Era of Personalized Medicine: Role of Next Generation Sequencing.
J Pers Med. 2021 May 23;11(6):454. doi: 10.3390/jpm11060454.
Zotero 插件